Renaissance Capital logo

VCYT News

Cardiovascular disease diagnostic company CardioDx revives IPO plans; updates financials and changes underwriters

CDX

CardioDx, which sells diagnostic tests for cardiovascular diseases, revived plans for its upcoming IPO in an amendment filed on Monday. The Palo Alto, CA-based company postponed its IPO in November 2013 citing poor market conditions. The company had...read more

US IPO Recap: 2013 passes 2012 in proceeds raised

A week with nine US IPOs pushed 2013's total proceeds raised to $43.4 billion, ahead of 2012's $42.4 billion and trailing only 2007’s $48.7 billion for the highest total since the tech bubble. October ended with 30 pricings (and 30 filings), putting 2013,...read more

Veracyte prices upsized IPO at $13, the low end of the range

Veracyte, which sells molecular diagnostic tests for thyroid cancer to reduce unnecessary surgeries, raised $65 million by offering 5.0 million shares at $13, the low end of the range of $13 to $15. The company originally planned to offer 4.7 million shares....read more

10 US IPOs planned for the week of Oct 28

The following IPOs are expected to price this week: 58.com (WUBA), an online classifieds marketplace serving local merchants and consumers in China, plans to raise $154...read more